Evidence map›Paper›PMID 34541260›Full record

ArticleUrology practice2020

Urologist practice structure and quality of prostate cancer care.

Parth K Modi, Phyllis Yan, Brent K Hollenbeck, Samuel R Kaufman, Tudor Borza, Ted A Skolarus, Florian R Schroeck, Andrew M Ryan, Vahakn B Shahinian, Lindsey A Herrel

Abstract read
In one paragraph

Article in Urology practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Parth K ModiDow Division for Health Services Research, Department of Urology, University of Michigan, Ann Arbor, MI.
Phyllis YanDow Division for Health Services Research, Department of Urology, University of Michigan, Ann Arbor, MI.
Brent K HollenbeckDow Division for Health Services Research, Department of Urology, University of Michigan, Ann Arbor, MI.
Samuel R KaufmanDow Division for Health Services Research, Department of Urology, University of Michigan, Ann Arbor, MI.
Tudor BorzaDow Division for Health Services Research, Department of Urology, University of Michigan, Ann Arbor, MI.
Ted A SkolarusDow Division for Health Services Research, Department of Urology, University of Michigan, Ann Arbor, MI.
Florian R SchroeckVA Outcomes Group, White River Junction VA Medical Center, VT, and The Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth College, Hanover, NH.
Andrew M RyanInstitute for Healthcare Policy & Innovation, University of Michigan, Ann Arbor, MI.
Vahakn B ShahinianDow Division for Health Services Research, Department of Urology, University of Michigan, Ann Arbor, MI.
Lindsey A HerrelDow Division for Health Services Research, Department of Urology, University of Michigan, Ann Arbor, MI.

Funding

De-implementation of low value castration for men with prostate cancerR37CA222885 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SAINI, SAMEER DEV, SKOLARUS, TED ALBERT · 2018 to 2023
$3.6M
AHRQ HHS R01 HS025707NCI NIH HHS R37 CA222885
6 · The paper itself

Abstract

objectiveTo examine three aspects of urologist practice structure that may affect quality of prostate cancer care: practice size, ownership of an intensity modulated radiation therapy (IMRT) device, participation within a multi-specialty group (MSG). Health care reforms focused on improving quality are particularly relevant for prostate cancer given its prevalence and concerns for overdiagnosis and overtreatment.

methodsUsing data from the Surveillance, Epidemiology and End-Results (SEER)-Medicare linked registry, we examined quality of prostate cancer treatment according to each treating urologist's practice size, type (single-specialty vs. MSG) and ownership of IMRT. Mixed models were used to adjust for patient differences.

resultsWe identified 22,412 men with newly diagnosed prostate cancer treated by 2,199 urologists during the study. We observed minimal differences for most quality metrics according to practice size, type, and ownership of IMRT. Adherence to all eligible quality metrics was better among MSGs compared to single specialty groups (20.0% adherence versus 18.2%, p=0.01) whereas there was no significant difference by ownership of IMRT (17.1% adherence in owners versus 18.9% non-owners, p=0.09).

conclusionDifferences in quality across practice size, type and ownership of IMRT were modest, with substantial room for improvement regardless of practice structure.

Indexed as

prostate cancerquality of careradiation therapyvalue

Identifiers

PMID34541260
PMCPMC8447938

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.